Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Darling Ingredients' helsemerkevare Rousselot kunngjør partnerskap med Terasaki-instituttet for biomedisinsk innovasjon
  • USA - Suomeksi
  • USA - Dansk
  • USA - Français
  • USA - Nederlands
  • USA - Deutsch
  • USA - Svenska
  • USA - English

Darling Ingredients’ Rousselot Health Brand Announces Partnership with Terasaki Institute for Biomedical Innovation

News provided by

Darling Ingredients Inc.

Jan 12, 2022, 13:48 ET

Share this article

Share toX

Share this article

Share toX

IRVING i Texas, 12. jan. 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) kunngjorde i dag at helsemerkevaren Rousselot, den globale lederen for collagen-baserte løsninger, har inngått et samarbeid med Terasaki-instituttet for biomedisinsk innovasjon (TIBI), et forskningsinstitutt i California med fokus på regenerative medisiner. Gjennom dette strategiske partnerskapet vil Rousselot og TIBI samarbeide om å utvikle gelatin-baserte terapier og deres translasjon til klinikken. Rousselot vil levere TIBI X-Pure®-modifiserte gelatiner, som X-Pure GelMA, samtidig som de utveksler innsikt i gelatinens virkemåte i instituttets forskning og kliniske studier.

Med mer enn 130 år med kompetanse på gelatin og kollagen, skapte Rousselot X-Pure®, et komplett utvalg av biomedisinske gelatiner og modifiserte gelatiner, kjennetegnet av deres enestående renhet (<10 EU/g endotoksin) og konsistens, i tillegg til fullt samsvar med GMP. Som en del av denne serien er Rousselots X-Pure® GelMA-modifiserte gelatiner allerede blitt testet og anerkjent for sin førsteklasses kvalitet av TIBIs forskere.

«Det er en glede for oss å kunne samarbeide med Rousselot og bruke Rousselots modifiserte gelatiner til forskningen vår,» sier Ali Khademhosseini, administrerende direktør for TIBI. «Modifiserte gelatiner har vist seg å være kraftige biomaterialer innen det regenerative medisinfeltet, og vi har brukt dem mye de siste årene. Jeg er sikker på at renset GelMA av høy kvalitet vil støtte både in vitro- og in vivo-forskningen og utviklingen vår. Med X-Pure GelMA vil vi kunne gjøre ytterligere fremskritt i den kliniske translasjonen av forskningen vår for å fremskynde utviklingen av nye terapier.»

«Det er en glede for oss å samarbeide med TIBI og deres verdenskjente forskerteam,» sa Randall C. Stuewe, styreleder og administrerende direktør for Darling Ingredients. «X-Pure®-modifiserte gelatiner har vært en vellykket innovasjon innen Rousselots biomedisinske divisjon. Deres unike egenskaper gjør dem ideelle for biomedisinsk forskning og etterfølgende klinisk translasjon. Vi er stolte av å være en del av TIBIs innsats for å utvikle levedyktige biomedisinske løsninger som vil hjelpe pasienter over hele verden.»

Samarbeidet er effektivt fra 1. januar 2022, og vil ha en innledende varighet på to år, noe som skaper et nært samarbeid mellom TIBIs eksperter på [mikronåler, 3D-bioprinting] og Rousselots eksperter på kollagen- og gelatin-baserte biomaterialer. 

Om Terasaki-instituttet for biomedisinsk innovasjon
TIBI er en ikke-kommersiell forskningsorganisasjon som finner opp og fremmer praktiske løsninger som gjenoppretter eller forbedrer enkeltpersoners helse. Instituttet er gjort mulig gjennom en donasjon fra den avdøde dr. Paul I. Terasaki, en pioner innenfor organtransplantasjon-teknologi. www.terasaki.org

Om Rousselot® Biomedical
Som det nyeste strategiske segmentet innen Rousselot, har vi lent oss på Rousselots over 130 år lange historie med global ekspertise og dokumenterte erfaring innen farmasøytiske gelatiner og kollagener for å kunne utvikle innovative serier med rensede, modifiserte og ikke-modifiserte gelatiner og kollagener til biomedisinsk bruk. Rousselot® X-Pure® og Rousselot® Quali-Pure™ gir unike fordeler for sikring av ytelse, kvalitet og sikkerhet fra A til Å, og leverer konsekvent kvalitet som støttes av omfattende vitenskapelige data og pågående forskning. Rousselot Biomedical har forpliktet seg til å støtte ende-til-ende-partnerskap for å bidra til å «fremme legevitenskapen.» www.rousselot.com/biomedical

Om Darling
Darling Ingredients Inc. (NYSE: DAR) er en verdensledende produsent av organiske ingredienser, og produserer et bredt spekter av bærekraftige protein- og fettprodukter. Selskapet er også en av de største produsentene av fornybar, ren energi. Darling har virksomhet på fem kontinenter. Selskapet samler inn avfall fra matindustrien, og deretter omdannes dette til spesialingredienser som hydrolysert kollagen, spiselig fett og matfett, animalske proteiner og måltider, plasma, ingredienser til kjæledyrfôr, drivstoffråvarer og grønn bioenergi. Darling Ingredients er utnevnt som en av «50 Sustainability and Climate Leaders in 2021». Les mer her: Darling Ingredients: The greenest Company on the planet - 50 Sustainability & Climate Leaders (50climateleaders.com). Selskapet selger ingredienser over hele verden og jobber med å styrke løftet om en bedre fremtid. Vi skaper produktapplikasjoner for helse, næringsstoffer og bioenergi samtidig som vi optimaliserer våre tjenester til næringskjeden. Darling eies 50 % av joint venture-partneren Diamond Green Diesel (DGD), Nord-Amerikas største produsent av fornybar diesel. Produktene reduserer klimagassutslippene med opptil 85 % sammenlignet med fossilt drivstoff. For ytterligere informasjon, besøk selskapets nettsted på http://www.darlingii.com.

For mer informasjon, kontakt:
Rousselot Biomedical
Catarina Da Silva
Kommunikasjonsleder for vitenskap
[e] [email protected] 

Sciad-kommunikasjoner
Maria Patey
[e] [email protected]

Investorrelasjoner
Melissa Gaither
VP, Global kommunikasjon
[e]  [email protected]

Logo – https://mma.prnewswire.com/media/1722122/Darling_Terasaki_Institute_Logo.jpg

Related Links

http://www.darlingii.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Darling Ingredients Inc. Announces Leadership Changes

Darling Ingredients Inc. Announces Leadership Changes

Darling Ingredients Inc. (NYSE: DAR) today announced that Brad Phillips, Executive Vice President and Chief Financial Officer, will retire from the...

Darling Ingredients Inc. Announces Avfuel Corporation Takes First Delivery of Sustainable Aviation Fuel produced by Diamond Green Diesel

Darling Ingredients Inc. Announces Avfuel Corporation Takes First Delivery of Sustainable Aviation Fuel produced by Diamond Green Diesel

Darling Ingredients Inc. (NYSE: DAR), the world's leading company turning food waste into sustainable products and producer of renewable energy,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Chemical

Chemical

Chemical

Chemical

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.